22Jun
22Jun
Lenabasum Continues to Show Promise for Treatment of Systemic Sclerosis in Extension Study
Treatment with Corbus Pharmaceuticals’ investigative therapy lenabasum (formerly known as anabasum) significantly improves the symptoms of diffuse cutaneous systemic sclerosis in a Phase 2 open-label extension study. Read more >>
22Jun
Corbus Pharmaceuticals Announces Resolution of Inflammation, Infection and Tissue Regeneration Conference
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory diseases, announced that it will be presenting at the Resolution of Inflammation, Infection and Tissue Regeneration Conference in partnership with the New York Academy of Sciences (NYAS), taking place on Tuesday, June 26, 2018 in New York City. Read more >>
20Jun
Grant to tackle enteritis in trout
KnipBio has been awarded a grant to study how changes in diet can alleviate enteritis and other diseases in farmed rainbow trout. Read more >>
18Jun
Lowell company developing ‘bone glue’ to help healing
Officials at LaunchPad Medical, LLC, say they're on the right track to breaking ground with this technology. They recently launched their product, Tetranite adhesive, onto the International Space Station for experiments in microgravity environment, and soon will publish the results from those trials. The company is also testing in animals based on strict FDA regulations, and officials hope to get FDA approval in the next year to start testing in humans. Read more >>
16Jun
US franchise Smoothie King launches Premama prenatal smoothie
US-based franchise company Smoothie King has partnered with prenatal vitamins company Premama to launch a new smoothie. Read more >>
16Jun
A health tech accelerator takes root in Amish country to support clinical validation
The Lab’s first cohort includes two companies — Philadelphia-based behavioral health startup NeuroFlow and Emovi, a Canadian medical device company that developed a knee pain assessment device geared for primary care settings. Read more >>
15Jun
MyoPro Powered Arm Brace Now Available for Teens with MS or Injuries, Myomo Announces
Myomo, a wearable medical robotics company, announced that MyoPro — its myoelectric orthosis or powered brace — is now available for use by teenagers with paralyzed or weakened arms due to injuries or neurological disorders such as multiple sclerosis (MS). Read more >>
14Jun
Corbus Pharmaceuticals Presents 1-Year Systemic Sclerosis and 6-Month Dermatomyositis Data from Open-Label Extension of Phase 2 Lenabasum Studies at EULAR 2018
Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today that data from open-label extensions (OLEs) of its systemic sclerosis (SSc) and dermatomyositis (DM) Phase 2 studies are being presented at the Annual European Congress of Rheumatology (EULAR 2018). Read more >>
14Jun